51
|
Attard TM, Young RJ, Stoner JA, Lynch HT. Population differences in familial adenomatous polyposis may be an expression of geographic differences in APC mutation pattern. ACTA ACUST UNITED AC 2007; 172:180-2. [PMID: 17213033 DOI: 10.1016/j.cancergencyto.2006.10.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2006] [Accepted: 10/03/2006] [Indexed: 10/24/2022]
|
52
|
Cao X, Hong Y, Eu KW, Loi C, Cheah PY. Singapore familial adenomatous polyposis (FAP) patients with classical adenomatous polyposis but undetectable APC mutations have accelerated cancer progression. Am J Gastroenterol 2006; 101:2810-7. [PMID: 17026565 DOI: 10.1111/j.1572-0241.2006.00842.x] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
OBJECTIVES Germline mutation in adenomatous polyposis coli (APC) is detected in up to 80% of familial adenomatous polyposis (FAP) patients worldwide. In this study, we evaluated clinical features and APC mutations of Singapore FAP patients and contrasted genotype-phenotype correlation with Caucasians from other regions of the world and between FAP patients with and without detectable APC mutations. METHODS We screened 242 members from 57 unrelated FAP families using a combination of cDNA protein truncation test, multiplex ligation-dependent probe amplification, and differential expression techniques. RESULTS APC germline mutations were detected in 50 families. In contrast to Caucasians, fundic gland polyposis in Singapore patients was associated with APC mutations throughout the coding region and osteomas were also not confined to codon 767-1573. There was also no FAP-associated hepatoblastoma or medullablastoma. APC mutation-negative patients from four families with mixed (adenomatous/hyperplastic/atypical juvenile) polyps were subsequently reclassified as hereditary mixed polyposis syndrome (HMPS) patients. APC mutation-negative patients with classical adenomatous polyposis were negative for MYH, beta-catenin, and Axin 1 mutations. These patients had a significantly older age at diagnosis (P < 0.001) and more colorectal cancers (P= 0.017) than patients with APC mutations. CONCLUSIONS We achieved a 94% (50/53) APC mutation detection rate via a combination of techniques, suggesting that the current detection rate is probably not exhaustive. Singapore patients have some features similar to and other features distinct from Caucasians. Furthermore, APC mutation-negative patients have accelerated cancer progression that merits closer surveillance.
Collapse
Affiliation(s)
- Xia Cao
- Department of Colorectal Surgery, Singapore General Hospital, Singapore
| | | | | | | | | |
Collapse
|
53
|
Muzaffarova TA, Pospekhova NI, Sachkov IY, Kuz'minov AM, Ginter EK, Karpukhin AV. New mutations in the APC gene in familial adenomatous polyposis: detection, characterization, and analysis. Bull Exp Biol Med 2005; 139:352-4. [PMID: 16027851 DOI: 10.1007/s10517-005-0292-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
The spectrum of mutations in the APC gene in familial adenomatous polyposis was detected in a sampling from the Russian population. Fifteen new mutations were found. Deletions associated with the loss of only 1 or 2 nucleotides (89% cases) prevailed among new (unique) mutations, while all known deletions were caused by the loss of 4 or 5 nucleotides. The detected differences in the deletion characteristics between unique and repeated mutations in the APC gene were typical of samples of patients from a number of populations. Samplings from different populations were heterogeneous by this sign. The incidence of 1-2-nucleotide deletions among unique and repeated deletions in the APC gene in patient samplings from different countries were in negative correlation.
Collapse
Affiliation(s)
- T A Muzaffarova
- Medical Genetic Research Center, Russian Academy of Medical Sciences, Moscow
| | | | | | | | | | | |
Collapse
|
54
|
Renkonen ET, Nieminen P, Abdel-Rahman WM, Moisio AL, Järvelä I, Arte S, Järvinen HJ, Peltomäki P. Adenomatous polyposis families that screen APC mutation-negative by conventional methods are genetically heterogeneous. J Clin Oncol 2005; 23:5651-9. [PMID: 16110024 DOI: 10.1200/jco.2005.14.712] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
PURPOSE One third of families with classical adenomatous polyposis (FAP), and a majority of those with attenuated FAP (AFAP), remain APC mutation-negative by conventional methods. Our purpose was to clarify the genetic basis of polyposis and genotype-phenotype correlations in such families. PATIENTS AND METHODS We studied a cohort of 29 adenomatous polyposis families that had screened APC mutation-negative by the protein truncation test, heteroduplex analysis, and exon-specific sequencing. The APC gene was investigated for large genomic rearrangements by multiplex ligation-dependent probe amplification (MLPA), and for allelic mRNA expression by single nucleotide primer extension (SNuPE). The AXIN2 gene was screened for mutations by sequencing. RESULTS Four families (14%) showed a constitutional deletion of the entire APC gene (three families) or a single exon (one family). Seven families (24%) revealed reduced or extinct mRNA expression from one APC allele in blood, accompanied by loss of heterozygosity in the APC region in six (75%) of eight tumors. In 15 families (52%), possible APC involvement could be neither confirmed nor excluded. Finally, as detailed elsewhere, three families (10%) had germline mutations in genes other than APC, AXIN2 in one family, and MYH in two families. CONCLUSION "APC mutation-negative" FAP is genetically heterogeneous, and a combination of MLPA and SNuPE is able to link a considerable proportion (38%) to APC. Significant differences were observed in clinical manifestations between subgroups, emphasizing the importance of accurate genetic and clinical characterization for the proper management of such families.
Collapse
Affiliation(s)
- Elise T Renkonen
- Department of Medical Genetics, Institute of Dentistry, Biomedicum Helsinki, PO Box 63 (Haartmaninkatu 8), FIN-00014 University of Helsinki, Helsinki, Finland
| | | | | | | | | | | | | | | |
Collapse
|
55
|
Truta B, Allen BA, Conrad PG, Weinberg V, Miller GA, Pomponio R, Lipton LR, Guerra G, Tomlinson IPM, Sleisenger MH, Kim YS, Terdiman JP. A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history. Fam Cancer 2005; 4:127-33. [PMID: 15951963 DOI: 10.1007/s10689-004-5814-0] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2004] [Accepted: 10/29/2004] [Indexed: 01/04/2023]
Abstract
OBJECTIVES Adenomatous polyposis of the colon is often secondary to an inherited mutation in adenomatous polyposis coli (APC) gene, however, approximately one third of patients have no family history of the disease. We studied the phenotype and genotype of adenomatous polyposis in patients without a family history. METHODS A cohort of 57 unrelated adenomatous polyposis patients were evaluated. Seventeen patients with no family history were compared with 40 patients who had a positive family history of the disease. Family history and medical records were collected and analyzed. Germline APC and Mut Y homologue (MYH) testing was undertaken. RESULTS Patients without a family history were diagnosed with polyposis at an older age (41 years vs. 32 years) and presenting more frequently with symptoms (76 vs 20, P < 0.05). The number of colonic polyps and frequency of extracolonic manifestation associated with adenomatous polyposis did not differ between the two groups. APC mutations were detected less frequently among patients without a family history of the disease (4 out of 17 vs 25 out of 40, P=0.007), even among those with greater than 100 colorectal adenomas (4 out of 12 versus 21 out of 29, P=0.03). One homozygous MYH mutation carrier (G382D) was detected among the six patients without a family history and without a germline APC mutation who were tested. CONCLUSIONS Adenomatous polyposis patients without a family history are usually diagnosed with symptoms, and at a later age. Phenotypically, they are similar to those with a family history. However, germline APC mutations are detected far less frequently in patients without a family history. A small percentage of these cases may be secondary to biallelic germline MYH mutations.
Collapse
Affiliation(s)
- Brindusa Truta
- Department of Medicine, Division of Gastroenterology and the Comprehensive Cancer Center, University of California-San Francisco, 2330 Post Street, San Francisco, CA 94115-1623, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
56
|
Brueckl WM, Ballhausen WG, Förtsch T, Günther K, Fiedler W, Gentner B, Croner R, Boxberger F, Kirchner T, Hahn EG, Hohenberger W, Wein A. Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma. Dis Colon Rectum 2005; 48:1275-81. [PMID: 15793634 DOI: 10.1007/s10350-004-0949-5] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
PURPOSE Desmoid tumors, also known as aggressive fibromatosis, occur with an incidence of 10 to 15 percent in patients affected by familial adenomatous polyposis, an autosomal inherited disease caused by germline mutations in the APC gene. However, sporadic forms with no hereditary background exist. The aim of this study was to find out whether there are APC germline mutations in apparently sporadic desmoid tumor patients without clinical or familial signs of familial adenomatous polyposis but with a family history of colorectal carcinoma in at least one family member. METHODS Genomic DNA and mRNA were isolated from peripheral blood leukocytes of index patients of eight nonrelated families. Mutation screening was performed using reverse transcriptase polymerase chain reaction-based protein truncation test for APC exons 1-14. The large APC exon 15 was scrutinized by the protein truncation test of four overlapping genomic fragments. Additionally, genomic DNA from five desmoid tumors was analyzed for loss of heterozygosity at D5S346 close to the APC locus. RESULTS No translational stop mutations typical for familial adenomatous polyposis could be found in the APC gene in any of the analyzed blood samples from the desmoid tumor patients. Additionally, no loss of heterozygosity at D5S346 was found in four of five desmoids; one tumor was not informative. CONCLUSIONS These results may suggest that patients with sporadic desmoids and no clinical signs of familial adenomatous polyposis detected on careful examination, esophagogastroduodenoscopy, and complete colonoscopy do not need to be tested routinely for germline mutations of the APC gene. However, as large studies dealing with this problem are absent, it might be more time and cost effective to perform an APC mutational analysis instead.
Collapse
Affiliation(s)
- Wolfgang M Brueckl
- Department of Internal Medicine I, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
57
|
Abstract
The genes associated with each of the inherited syndromes of colon cancer have now been identified, and genetic testing is available for diagnosis. These syndromes include familial adenomatous polyposis, hereditary nonpolyposis colorectal cancer, Peutz-Jeghers syndrome, juvenile polyposis syndrome, and, possibly, Cowden's syndrome. Clinical genetic testing approaches have been developed for each of these syndromes and are now a part of accepted clinical care. Disease-causing mutations can be found in the majority of families affected with one of the inherited syndromes, and, most importantly, once a mutation is found in an index case of the family, relatives can be tested for the presence or absence of that mutation with near 100% accuracy. Cancer screening and management in syndrome families is then based on the results of genetic testing. For the physician to order and properly interpret genetic tests, a basic understanding of the types of mutations that lead to inherited disease and the methods for detecting them is vital. These issues will be presented. Additional clinical issues somewhat unique to genetic testing include genetic counseling and informed consent for genetic testing, both of which will also be reviewed. Often the most difficult aspect of genetic testing is deciding which patients and families should undergo the testing. Furthermore, this issue is quite specific for each of the syndromes. Thus, following presentation of general principles of selection for genetic testing, a detailed approach for identifying persons who should undergo testing for each of the individual syndromes will be given, together with relevant descriptions of the syndromes. Finally, the ongoing work to discover new and possibly more common but less penetrant colon cancer susceptibility genes that cause common familial colon cancer will be presented.
Collapse
Affiliation(s)
- Randall Burt
- Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah 84112, USA.
| | | |
Collapse
|
58
|
Mihalatos M, Apessos A, Dauwerse H, Velissariou V, Psychias A, Koliopanos A, Petropoulos K, Triantafillidis JK, Danielidis I, Fountzilas G, Agnantis NJ, Nasioulas G. Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients. BMC Cancer 2005; 5:40. [PMID: 15833136 PMCID: PMC1097718 DOI: 10.1186/1471-2407-5-40] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2005] [Accepted: 04/15/2005] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Familial Adenomatous Polyposis (FAP) is caused by germline mutations in the APC (Adenomatous Polyposis Coli) gene. The vast majority of APC mutations are point mutations or small insertions/deletions which lead to truncated protein products. Splicing mutations or gross genomic rearrangements are less common inactivating events of the APC gene. METHODS In the current study genomic DNA or RNA from ten unrelated FAP suspected patients was examined for germline mutations in the APC gene. Family history and phenotype were used in order to select the patients. Methods used for testing were dHPLC (denaturing High Performance Liquid Chromatography), sequencing, MLPA (Multiplex Ligation - dependent Probe Amplification), Karyotyping, FISH (Fluorescence In Situ Hybridization) and RT-PCR (Reverse Transcription - Polymerase Chain Reaction). RESULTS A 250 Kbp deletion in the APC gene starting from intron 5 and extending beyond exon 15 was identified in one patient. A substitution of the +5 conserved nucleotide at the splice donor site of intron 9 in the APC gene was shown to produce frameshift and inefficient exon skipping in a second patient. Four frameshift mutations (1577insT, 1973delAG, 3180delAAAA, 3212delA) and a nonsense mutation (C1690T) were identified in the rest of the patients. CONCLUSION Screening for APC mutations in FAP patients should include testing for splicing defects and gross genomic alterations.
Collapse
Affiliation(s)
- Markos Mihalatos
- Molecular Biology Research Center HYGEIA – «Antonis Papayiannis», Athens
| | - Angela Apessos
- Molecular Biology Research Center HYGEIA – «Antonis Papayiannis», Athens
| | - Hans Dauwerse
- Center for Human and Clinical Genetics, Leiden University Medical Center, The Netherlands
| | - Voula Velissariou
- Cytogenetics Laboratory, Department of Genetics and Molecular Biology, Mitera Maternity and Surgical Center, Athens, Greece
| | - Aristidis Psychias
- Hygeia Ofthalmos, Diagnostic and Therapeutic Center of Athens HYGEIA S.A., Athens, Greece
| | - Alexander Koliopanos
- Surgical Clinic, General State Hospital of Athens "G. Gennimatas", Athens, Greece
| | | | | | - Ioannis Danielidis
- Gastroenterology Department Diagnostic and Therapeutic Center of Athens HYGEIA S.A., Athens Greece
| | - George Fountzilas
- AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki Greece
| | - Niki J Agnantis
- Department of Pathology, Medical School, University of Ioannina, Ioannina, Greece
| | - Georgios Nasioulas
- Molecular Biology Research Center HYGEIA – «Antonis Papayiannis», Athens
| |
Collapse
|
59
|
Chetty R, Salahshor S, Bapat B, Berk T, Croitoru M, Gallinger S. Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis. J Clin Pathol 2005; 58:97-101. [PMID: 15623495 PMCID: PMC1770535 DOI: 10.1136/jcp.2004.020925] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
A 67 year old man with a clinical diagnosis of attenuated familial adenomatous polyposis (AFAP) and a past history of synchronous colon cancers in the transverse colon was also found to have an intraductal papillary mucinous neoplasm (IPMN) of the pancreas. In addition, several foci of heterotopic gastric oxyntic mucosa were noted in the duodenum, interspersed with flat and polypoid adenomas. The duodenal adenomas showed low grade dysplasia, loss of adenomatous polyposis coli (APC) protein expression, but retention of beta catenin staining, localised to the nucleus and cytoplasm. The IPMN in the pancreas showed an identical immunohistochemical profile to the duodenal adenomas. The heterotopic gastric foci in the duodenum were negative for the APC protein, and beta catenin staining was membranous in location. Although the patient did not show germline truncating APC mutations or mutations in the MYH gene, the past history, clinical features, and immunohistochemical profile of the various lesions suggest strongly that the IPMN is part of the spectrum of lesions encountered in AFAP. Whether the heterotopic oxyntic gastric mucosa in the duodenum is also related is unclear, but it may represent a forme fruste of fundic gland polyps.
Collapse
Affiliation(s)
- R Chetty
- Department of Pathology, University of Toronto and University Health Network, Toronto, ON M5G 2M9, Canada.
| | | | | | | | | | | |
Collapse
|
60
|
Järvinen HJ. Hereditary cancer: guidelines in clinical practice. Colorectal cancer genetics. Ann Oncol 2005; 15 Suppl 4:iv127-31. [PMID: 15477295 DOI: 10.1093/annonc/mdh916] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Affiliation(s)
- H J Järvinen
- Helsinki University Central Hospital, Department of Surgery, Division of Gastroenterology, Finland
| |
Collapse
|
61
|
Wei SC, Su YN, Tsai-Wu JJ, Wu CHH, Huang YL, Sheu JC, Wang CY, Wong JM. Genetic analysis of the APC gene in Taiwanese familial adenomatous polyposis. J Biomed Sci 2004; 11:260-5. [PMID: 14966376 DOI: 10.1007/bf02256569] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2003] [Accepted: 10/24/2003] [Indexed: 01/12/2023] Open
Abstract
Colorectal cancer has become the third leading cause of death from cancer in Taiwan. Familial adenomatous polyposis (FAP) is an autosomal dominant inherited disease characterized by the presence of multiple adenomatous polyps in the colon and rectum. The gene responsible for FAP (APC) was cloned in 1991. Extensive analyses of the mutation spectra in FAP kindreds have been performed in different countries, but the results have been highly variable (30-80%). In this study, we used denaturing high-performance liquid chromatography (DHPLC) followed by automatic sequencing in an effort to establish the mutation spectrum of APC from DNA of peripheral blood cells. Among the 6 FAP probands analyzed, mutations were detected in 3 (50%), 2 of which were novel. The first novel mutation was at codon 2166, with a C to T transition, resulting in a stop codon. The second novel mutation was at codon 1971, with a C to G transversion, resulting in an amino acid change from serine to cysteine. The third mutation involved an A insertion in the sequence of -AAAAAA- at codons 1554-1556, which created a downstream stop codon (codon 1558). This study is the first to report mutation analysis in Taiwanese FAP probands.
Collapse
Affiliation(s)
- Shu-Chen Wei
- Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan, ROC
| | | | | | | | | | | | | | | |
Collapse
|
62
|
Abstract
Periampullary cancers make up 5% of all gastrointestinal cancers. The complexity of the periampullary anatomy makes determination of the origin of some of these tumors difficult. However, advances in imaging have helped with diagnosis as well as defining the extent of the lesion and its potential resectability. For many of these tumors, surgery is the recommended treatment. However, endoscopic removal is being extended to different lesions with encouraging preliminary results. Improvements in overall prognosis for periampullary tumors will be limited until diagnosis can be established earlier in the course of the disease and adjuvant therapies become more effective.
Collapse
Affiliation(s)
- William A Ross
- Department of Gastrointestinal Medicine and Nutrition, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 436, Houston, TX 77030, USA.
| | | |
Collapse
|
63
|
Abstract
The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Approximately 5-10% of all cancers are inherited, the majority in an autosomal dominant manner with incomplete penetrance. While this is a small fraction of the overall cancer burden worldwide, the molecular genetic discoveries that have resulted from the study of families with heritable cancer have not only changed the way these families are counselled and managed, but have shed light on molecular regulatory pathways important in sporadic tumour development as well. In this review, we consider 10 of the more highly penetrant cancer syndromes, with emphasis on those predisposing to breast, colon, and/or endocrine neoplasia. We discuss the prevalence, penetrance, and tumour spectrum associated with these syndromes, as well as their underlying genetic defects.
Collapse
Affiliation(s)
- Rebecca Nagy
- Clinical Cancer Genetics Program, Comprehensive Cancer Center, Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Columbus 43221, USA.
| | | | | |
Collapse
|
64
|
Neklason DW, Solomon CH, Dalton AL, Kuwada SK, Burt RW. Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype. Fam Cancer 2004; 3:35-40. [PMID: 15131404 DOI: 10.1023/b:fame.0000026824.85766.22] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
The adenomatous polyposis coli (APC) protein is a tumor suppressor frequently involved in the development of inherited and sporadic colon cancers. Somatic mutations of the APC gene are found in 80% of all colon cancers. Inherited mutations result in familial adenomatous polyposis (FAP) as well as an attenuated form of this syndrome. FAP is characterized by the early age onset of hundreds to thousands of colonic adenomatous polyps and a virtual certainty of colon cancer unless the colon is removed. The attenuated form of FAP (AFAP) is characterized by fewer adenomas, later onset of adenomas and cancer, and a decreased lifetime cancer risk. We report a 37-year-old man with a history of more than 50 colonic adenomatous polyps, located predominately in the right colon. An insertion of a single thymidine between the second and third base pairs of intron 4 of the APC gene was identified (c.531+2_531+3insT). Monoallelic hybrid cells harboring a single copy of human chromosome 5 were generated from patient lymphoblasts. Sequencing of the APC cDNA product from these cells revealed a single RNA transcript with aberrant splicing in the mutant mRNA whereby exon 4 is deleted. The translational reading frame is shifted after codon 140 and a translational stop is generated predicting a truncated protein of 147 amino acids, thus indicating that the intronic mutation is disease causing. The lack of a secondary transcript from the mutant allele suggests that incomplete exon skipping is not the molecular mechanism behind the attenuated phenotype.
Collapse
Affiliation(s)
- Deborah W Neklason
- Department of Oncological Sciences, University of Utah, Salt Lake City, USA.
| | | | | | | | | |
Collapse
|
65
|
Bisgaard ML, Ripa R, Knudsen AL, Bülow S. Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype. Gut 2004; 53:266-70. [PMID: 14724162 PMCID: PMC1774914 DOI: 10.1136/gut.2003.019042] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
BACKGROUND Development of more than 100 colorectal adenomas is diagnostic of the dominantly inherited autosomal disease familial adenomatous polyposis (FAP). Germline mutations can be identified in the adenomatous polyposis coli (APC) gene in approximately 80% of patients. The APC protein comprises several regions and domains for interaction with other proteins, and specific clinical manifestations are associated with the mutation assignment to one of these regions or domains. AIMS The phenotype in patients without an identified causative APC mutation was compared with the phenotype in patients with a known APC mutation and with the phenotypes characteristic of patients with mutations in specific APC regions and domains. PATIENTS Data on 121 FAP probands and 149 call up patients from 70 different families were extracted from the Danish Polyposis register. METHODS Differences in 16 clinical manifestations were analysed according to the patient's mutational status. Two sided independent t sample test, two sided chi(2) test, and odds ratios were calculated. RESULTS Patients without identified APC mutations had a unique and severe phenotype, which was roughly described as: young age at diagnosis and subsequent death in spite of development of few colorectal adenomas; low risk of involvement of the upper gastrointestinal tract, as reflected by a low mean Spigelman stage, and a low risk of fundic gland polyposis. Finally, they had significantly fewer affected family members, although they do not themselves more often represent an isolated case. CONCLUSIONS The severe phenotype should be considered when counselling FAP families in which attenuated FAP is excluded and in which a causative APC mutation has not been identified.
Collapse
Affiliation(s)
- M L Bisgaard
- The Danish Polyposis Register, Department of Surgical Gastroenterology 435, Hvidovre University Hospital, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.
| | | | | | | |
Collapse
|
66
|
Abstract
Hereditary colorectal cancer syndromes are classified according to the presence of unusually large number of adenomatous or hamartomatous polyps, or their absence. The latter category includes hereditary non-polyposis colorectal cancer (Lynch syndrome) and its variants Muir-Torre and Turcot's syndromes. Adenomatous polyposis syndromes include familial adenomatous polyposis (FAP) and its variants, and the recently identified MYH- (mutY homolog)-associated polyposis. Hamartomatous polyposis syndromes include juvenile polyposis, Peutz-Jeghers syndrome, and Cowden syndrome, which is now included within the broader category 'PTEN (phosphatase and tensin homolog) hamartoma tumour syndrome'. Other syndromes such as the 'hereditary breast and colon cancer' and 'familial colorectal cancer' are not yet fully characterized. This review addresses the molecular basis of these syndromes with particular reference to the recent advances in this rapidly progressive field and the applications of such knowledge in diagnosis and management.
Collapse
Affiliation(s)
- Wael M Abdel-Rahman
- Department of Medical Genetics, University of Helsinki, Helsinki, Finland. Wael.Abdel-Rahman@helsinki
| | | |
Collapse
|
67
|
Abstract
Familial adenomatous polyposis predisposes to colorectal cancer through multiple colorectal adenomas. The age of onset of adenomas and their number vary between families affected by this dominantly inherited trait, even within families. The same applies to a variety of associated manifestations including epidermoid cysts, osteomas, dental anomalies, desmoid tumours, retinal pigmentation and upper gastrointestinal polyps. The phenotype variation has a relationship with the site of truncating mutations on the APC gene. Thus, mutations at the mutation cluster region (codons 1250-1400) tend to cause early onset and severe polyposis whereas osteomas, dental changes and desmoids are most frequent in patients with the mutation 3' to codon 1400. The correlation observed, however, seems quite complex. Explanations may include variable interference of different mutant APC proteins on the wildtype APC function. There is also evidence suggesting an effect of modifier genes. The clinical applications of genotype-phenotype correlation on the management of patients with familial adenomatous polyposis remain limited apart from predictive genetic testing.
Collapse
Affiliation(s)
- Heikki J Järvinen
- Department of Gastroenterological Surgery, Helsinki University Central Hospital, Helsinki, Finland.
| | | |
Collapse
|
68
|
Venesio T, Balsamo A, Rondo-Spaudo M, Varesco L, Risio M, Ranzani GN. APC haploinsufficiency, but not CTNNB1 or CDH1 gene mutations, accounts for a fraction of familial adenomatous polyposis patients without APC truncating mutations. J Transl Med 2003; 83:1859-66. [PMID: 14691304 DOI: 10.1097/01.lab.0000106722.37873.8d] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Familial adenomatous polyposis (FAP) is an autosomal dominant condition characterized by the development of hundreds to thousands of colorectal adenomatous polyps. In addition to the classic form, there is also attenuated polyposis (attenuated adenomatous polyposis coli; AAPC), which is characterized by a milder phenotype. FAP/AAPC is caused by germline mutations in the adenomatous polyposis coli (APC) gene. Very recently, germline mutations in the base-excision repair gene MYH have been associated with recessive inheritance of multiple colorectal adenomas in a subset of patients. APC pathogenic alterations are mostly (>95%) represented by frameshift or nonsense mutations leading to the synthesis of a truncated protein. We identified 20 APC truncating mutation carriers out of 30 FAP/AAPC patients from different Italian kindreds. In the remaining 10 patients, we searched for alterations other than truncating mutations by enzymatic mutation detection, real-time quantitative RT-PCR, and genotyping of polymorphic markers encompassing the APC locus. Moreover, to assess whether mutations of genes interacting with APC can substitute or act in association with APC alterations, we sequenced both CTNNB1 (beta-catenin) and CDH1 (E-cadherin) genes. No CTNNB1 or CDH1 mutations were found. On the contrary, four patients showed a reduced APC gene expression compared with healthy subjects. In three of the four cases, genotyping results were compatible with a constitutive allelic deletion. In one case this conclusion was confirmed by haplotype segregation analysis. Our results support the notion that FAP/AAPC can result from APC constitutive haploinsufficiency, with gene deletion being a possible cause of reduced gene expression.
Collapse
Affiliation(s)
- Tiziana Venesio
- Unit of Pathology, Institute for Cancer Research and Treatment, Candiolo-Torino, Genova, Italy
| | | | | | | | | | | |
Collapse
|
69
|
Enholm S, Hienonen T, Suomalainen A, Lipton L, Tomlinson I, Kärjä V, Eskelinen M, Mecklin JP, Karhu A, Järvinen HJ, Aaltonen LA. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. THE AMERICAN JOURNAL OF PATHOLOGY 2003; 163:827-32. [PMID: 12937124 PMCID: PMC1868242 DOI: 10.1016/s0002-9440(10)63443-8] [Citation(s) in RCA: 106] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Recessively inherited mutations in the base excision repair gene MYH have recently been associated with predisposition to colorectal adenomas and cancer in materials selected for occurrence of multiple adenomas. In particular, variants Y165C and G382D have been shown to play a role in Caucasian patients. To evaluate the contribution of MYH mutations to colorectal cancer burden on the population level, and to examine the MYH-associated phenotype in an unselected series of colorectal cancer patients, we determined the frequencies of Y165C and G382D MYH mutations in a population-based series of 1042 Finnish colorectal cancer patients. Four (0.4%) patients had both MYH alleles mutated. Although all these patients had multiple adenomatous polyps, the phenotypes tended to be less extreme than in previous studies on selected cases. The lowest number of colorectal adenomas at the time of cancer diagnosis was five. Cases with one mutant MYH allele were subjected to sequencing of all exons to detect possible Finnish founder mutations, but no additional changes were detected. The Y165C and G382D variants were not present in 424 Finnish cancer-free controls showing that MYH mutations are not enriched in the population. As evaluated against national Finnish Polyposis Registry data MYH-associated colorectal cancer appears to be as common as colorectal cancer associated with familial adenomatous polyposis.
Collapse
Affiliation(s)
- Susa Enholm
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Tuija Hienonen
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Anu Suomalainen
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Lara Lipton
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Ian Tomlinson
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Vesa Kärjä
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Matti Eskelinen
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Jukka-Pekka Mecklin
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Auli Karhu
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Heikki J. Järvinen
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| | - Lauri A. Aaltonen
- From the Department of Medical Genetics,*Programme of Neurosciences, and the Department of Neurology,†Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; the Molecular and Population Genetics Laboratory,‡Cancer Research UK, London, United Kingdom; the Departments of Pathology§and Surgery,¶Kuopio University Central Hospital, Kuopio, Finland; the Department of Surgery,∥Jyväskylä Central Hospital, Jyväskylä, Finland; the Second Department of Surgery,**Helsinki University Central Hospital, Helsinki, Finland
| |
Collapse
|
70
|
Grandjouan S. Surveillance des sujets à risque très élevé de cancer colorectal (polyposes, cancer colique héréditaire sans polypose). ACTA ACUST UNITED AC 2002. [DOI: 10.1007/bf03018872] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|